CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Co-Diagnostics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$0.67+0.01 (+1.83%)

Close on Oct 19, 2026

Market cap: $2.87M
P/E (TTM): –
Dividend yield: –

Co-Diagnostics, Inc. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31
Cash & Equivalents	12	2.94	15	23	89	43	0.89	0.95	3.53	1.00	0.03
Short-Term Investments	–	27	44	58	1.26	4.34	–	–	–	–	–
Cash & Short-Term Investments	12	30	59	81	90	47	0.89	0.95	3.53	1.00	0.03
Receivables	0.19	0.13	0.30	3.45	21	12	0.13	0.01	–	–	–
Inventory	0.99	1.07	1.66	5.31	2.00	8.00	0.20	0.02	0.01	–	–
Prepaid Expenses & Other	0.58	1.34	1.60	0.76	2.34	0.37	0.36	0.07	0.91	0.21	–
Total Current Assets	14	32	62	93	115	68	1.58	1.05	4.45	1.21	–
Property, Plant & Equipment	2.27	2.76	3.04	2.54	1.93	0.95	0.20	0.16	0.17	0.09	–
Gross Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	0.17	–
Accumulated Depreciation	-3.91	-3.28	-2.23	-1.37	-0.62	-0.30	-0.20	–	–	-0.08	–
Operating Lease Right-of-Use Assets	1.21	2.11	2.97	0.37	–	–	–	–	–	–	–
Goodwill	–	–	–	–	15	–	–	–	–	–	–
Intangible Assets	7.22	26	26	27	27	–	–	–	–	–	–
Deferred Tax Assets	–	–	–	–	–	0.55	–	–	–	–	–
Total Assets	25	64	95	123	160	71	2.22	1.55	4.66	1.30	–
Accounts Payable	1.88	3.29	1.48	0.95	0.61	0.60	0.01	0.15	0.04	0.03	–
Accrued Expenses	0.87	2.56	2.17	0.93	3.86	2.85	0.20	0.17	0.10	0.10	–
Current Portion of Long-Term Debt	–	–	–	–	–	–	–	1.91	–	2.56	–
Current Debt	–	–	–	–	–	–	–	1.91	–	2.56	–
Current Portion of Leases	0.66	0.92	0.84	0.30	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	–	–	2.21	0.19	–	–	–	–	–
Deferred Revenue (Current)	0.01	0.04	0.36	–	0.15	0.31	0.00	–	0.01	–	–
Total Current Liabilities	3.54	7.32	5.75	3.87	13	4.06	0.33	2.35	0.63	3.85	–
Long-Term Debt	–	–	–	–	–	–	–	1.91	0.28	0.45	–
Long-Term Leases	0.57	1.24	2.15	0.05	–	–	–	–	–	–	–
Operating Lease Liabilities	1.24	2.15	2.99	0.35	–	–	–	–	–	–	–
Deferred Tax Liabilities	–	–	–	2.42	7.23	–	–	–	–	–	–
Total Liabilities	4.11	9.69	9.31	8.57	26	4.54	0.48	2.61	0.81	4.29	–
Total Debt	–	–	–	–	–	–	–	3.82	0.28	3.00	–
Preferred Stock	–	–	–	–	–	–	0.00	–	–	–	–
Common Stock	0.07	0.04	0.04	0.03	0.03	0.03	0.02	0.01	0.01	0.01	–
Additional Paid-In Capital	117	102	97	88	80	49	27	18	16	2.46	–
Retained Earnings	-80	-33	4.60	40	54	18	-25	-19	-12	-5.46	–
Treasury Stock	-16	-16	-16	-14	–	–	–	–	–	–	–
Comprehensive Income & Other	–	0.42	0.15	0.29	–	–	–	–	–	–	–
Shareholders' Equity	21	54	86	115	134	67	1.74	-1.06	3.85	-2.99	-1.15
Total Equity	21	54	86	115	134	67	1.74	-1.06	3.85	-2.99	-1.15
Total Liabilities & Equity	25	64	95	123	160	71	2.22	1.55	4.66	1.30	–
Shares Outstanding(shares)	2.10	1.10	1.04	1.03	1.13	0.95	0.58	0.43	0.41	0.33	–
Deposits	–	–	–	–	–	–	0.25	–	2.20	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 43.5%
Operating margin: -6787.6%
Net margin: -6523.0%
Return on equity, FY2025: -125.9%

Financial strength

Current ratio: 1.81
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 127.5%

Valuation

P/E ratio: –
Price to sales: 3.98
Price to book: 0.23
Dividend yield: –